한빛사논문
Yunjin Go1,2,3†, Jestlin Tianthing Ng1,2,3†, Darren Wan‑Teck Lim4 and Su Bin Lim1,2,3*
1Department of Biochemistry & Molecular Biology, Ajou University School of Medicine, Suwon 16499, Korea
2Infamm‑Aging Translational Research Center, Ajou University Medical Center, Suwon 16499, Korea
3Department of Biomedical Sciences, Graduate School of Ajou University, Suwon 16499, Korea
4Division of Medical Oncology, National Cancer Centre, Singapore 16853, Singapore
†Yunjin Go and Jestlin Tianthing Ng have contributed equally to this work.
*Correspondence: Su Bin Lim
Abstract
Hepatocellular carcinoma (HCC) presents a major health issue worldwide. This study introduces the HepScope gene set, developed through a hybrid approach that utilizes single-cell RNA sequencing (scRNA-seq), spatial transcriptomics (stRNA-seq), bulk RNA-seq, and proteomics data, along with the adaptation of Convolutional Neural Network (CNN) techniques. Comprising 113 genes significantly upregulated in malignant hepatocytes, HepScope gene set includes 77 genes unique to this set compared to other HCC-related gene sets. Unlike existing solutions, HepScope gene set demonstrated superior discriminatory power in distinguishing malignant from non-malignant hepatocytes, as validated by Seurat's module score, outperforming five other gene sets across multiple datasets. A 1D-CNN model, specifically adapted for the HepScope gene set, achieved superior accuracy (0.71), AUROC (0.82), and F1 score (0.85) compared to models trained on other gene sets, underscoring its enhanced predictive precision and robustness. Rigorous cross-validation and benchmarking against alternative models confirmed HepScope’s consistent performance. Additionally, we evaluated the prognostic capability of the HepScope gene set across two independent cohorts, demonstrating that the HepScope-based risk score is a strong independent predictor of overall and disease-free survival, making it a valuable tool for patient prognosis. Collectively, our findings position HepScope as a promising gene set for both diagnostic and prognostic applications in HCC, highlighting its potential in precision medicine for HCC and offering insights into personalized therapy development.
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기